Integrative medicine in multiple myeloma and plasma cell disorders
Name:
1-s2.0-S0965229923000262.pdf
Size:
367.6Kb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Hematology Oncology, University of ArizonaUniversity of Arizona Cancer Center, University of Arizona
Department of Medicine, University of Arizona
Issue Date
2023-03-02
Metadata
Show full item recordPublisher
Churchill LivingstoneCitation
Okolo, O., Wertheim, B. C., Larsen, A., Sweeney, N. W., Ahlstrom, J. M., & Gowin, K. (2023). Integrative medicine in multiple myeloma and plasma cell disorders. Complementary Therapies in Medicine, 73, 102939.Rights
© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Introduction: Integrative Medicine (IM) use and efficacy is poorly defined in those with plasma cell disorders (PCD). A 69-question survey on the subject was hosted on HealthTree.org for 3 months. Method: The survey included questions about complementary practice use, PHQ-2 score, quality of life, and more. Mean outcome values were compared between IM users and non-users. Proportions of supplement users and IM patients were compared between patients currently on myeloma specific treatment and patients not currently on treatment. Results: The top 10 IM modalities reported among 178 participants were aerobic exercise (83 %), nutrition (67 %), natural products (60 %), strength exercise (52 %), support groups (48 %), breathing exercises (44 %), meditation (42 %), yoga (40 %), mindfulness-based stress reduction (38 %), and massage (38 %). The survey showed most patients participated in IM modalities, though they felt uncomfortable discussing them with their oncologist. Participant characteristics were compared between groups (users and non-users) using two-sample t-tests and chi-square tests. Use of vitamin C (3.6 vs. 2.7; p = 0.01), medical marijuana (4.0 vs. 2.9; p = 0.03), support groups (3.4 vs. 2.7; p = 0.04), and massage (3.5 vs. 2.7; p = 0.03) were associated with a higher quality of life scores on MDA-SI MM. There were no other significant associations between supplement use or IM practices and the MDA-SI MM, brief fatigue inventory, or PHQ-2. Conclusion: This study provides a foundation in the understanding of IM use in PCD, but more research is needed to evaluate individual IM interventions and their efficacy. © 2023Note
Open access articleISSN
0965-2299PubMed ID
36868288Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1016/j.ctim.2023.102939
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
Related articles
- The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
- Authors: Gowin K, Langlais BT, Kosiorek HE, Dueck A, Millstine D, Huberty J, Eckert R, Mesa RA
- Issue date: 2020 Dec
- Integrative medicine use in patients with cutaneous T-Cell lymphoma: A cross-sectional survey study.
- Authors: Mahurin HM, Tarabadkar E, Hippe DS, Lachance K, Kim EJ, Loggers ET, Shinohara MM
- Issue date: 2021 Sep
- Infectious diseases physicians' attitudes and practices related to complementary and integrative medicine: results of a national survey.
- Authors: Shere-Wolfe KD, Tilburt JC, D'Adamo C, Berman B, Chesney MA
- Issue date: 2013
- Integrative Medicine Patients Have High Stress, Pain, and Psychological Symptoms.
- Authors: Wolever RQ, Goel NS, Roberts RS, Caldwell K, Kligler B, Dusek JA, Perlman A, Dolor R, Abrams DI
- Issue date: 2015 Jul-Aug
- Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER) of the BraveNet practice-based research network: study protocol.
- Authors: Dusek JA, Abrams DI, Roberts R, Griffin KH, Trebesch D, Dolor RJ, Wolever RQ, McKee MD, Kligler B
- Issue date: 2016 Feb 4